Metraipolis › archive › dc_a57dcb81c4e2

Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report — Europe PMC PMID:42370133

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42370133
DOI
10.3389/fonc.2026.1820428
License (as archived)
solo-consultazione
Archived
2026-10-31T13:50:38.371Z
SHA-256 of the archived text
42477ed0d4df79c4a281daae0312cddf589340b1237baa69a7a9c9dedeb4e75a
Stable URL of this page
https://metraipolis.com/documento/dc_a57dcb81c4e2

How to cite

Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report — Europe PMC PMID:42370133 — Europe PMC (en), https://europepmc.org/article/MED/42370133 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a57dcb81c4e2 (Metraipolis archive dc_a57dcb81c4e2, sha256 42477ed0d4df79c4a281daae0312cddf589340b1237baa69a7a9c9dedeb4e75a)
BibTeX
@misc{dca57dcb81c4e2,
  title = {Combined SSTR2-targeted Analogue with 177Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report — Europe PMC PMID:42370133},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42370133},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a57dcb81c4e2; sha256 42477ed0d4df79c4a281daae0312cddf589340b1237baa69a7a9c9dedeb4e75a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42370133. Agents can read the archived copy with the MCP tool read_document.